![[PODCAST] Daily Dose @ 5: M'sia records 2,733 COVID-19 cases in 24-hours, Myanmar youth train to fight junta](https://resizer-awani.eco.astro.com.my/tr:w-177,h-100,q-100,f-auto/https://img.astroawani.com/2020-09/71600683822_DailyDose.jpg "[PODCAST] Daily Dose @ 5: M'sia records 2,733 COVID-19 cases in 24-hours, Myanmar youth train to fight junta")
[PODCAST] Daily Dose @ 5: M'sia records 2,733 COVID-19 cases in 24-hours, Myanmar youth train to fight junta
A rundown of the most important stories you need to know for the day, from the newsroom of Astro AWANI.
Tue Apr 27 2021
WHO study says remdesivir did not cut hospital stay or mortality in COVID-19 patients
The regimens appeared to have little or no effect on 28-day mortality or the length of the in-hospital course among COVID-19 patients.
Fri Oct 16 2020
Gilead's remdesivir shaved five days off COVID-19 recovery time, reduced risk of death in some
Results of the overall study suggested the drug may reduce mortality, but the benefit was not statistically significant.
Fri Oct 09 2020
Trump to spend days at military hospital after COVID-19 diagnosis
Trump received a first dose of Remdesivir, an intravenous antiviral drug sold by Gilead Sciences Inc.
Sat Oct 03 2020
COVID-19: Singapura luluskan penggunaan Remdesivir untuk rawat pandemik
Singapura mengikuti jejak langkah Amerika Syarikat (AS) apabila meluluskan penggunaan ubat antivirus remdesivir untuk merawat pesakit positif COVID-19.
Thu Jun 11 2020
COVID-19: Jepun luluskan penggunaan remdesivir untuk rawat pandemik
Kelulusan penggunaan remdesivir dibuat di bawah langkah-langkah khas, bagi merawat pesakit COVID-19 dengan simptom serius.
Thu May 07 2020